These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12631372)

  • 41. Variations in the circulating heparin levels during maintenance hemodialysis in patients with end-stage renal disease.
    Kaneva K; Bansal V; Hoppensteadt D; Cunanan J; Fareed J
    Clin Appl Thromb Hemost; 2013; 19(4):449-52. PubMed ID: 23463188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The rationale for the use of low molecular weight heparin for hemodialysis treatments.
    Davenport A
    Hemodial Int; 2013 Oct; 17 Suppl 1():S28-32. PubMed ID: 24134328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK; Berry LR; Monagle PT; Andrew M
    Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
    Momi S; Nasimi M; Colucci M; Nenci GG; Gresele P
    Haematologica; 2001 Mar; 86(3):297-302. PubMed ID: 11255277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beneficial effect of low molecular weight heparin on the hemodialysis model in dogs.
    Hamano S; Komatsu H; Ikeda S; Takahashi K; Oguma Y; Sakuragawa N
    Thromb Res; 1989 Aug; 55(4):439-49. PubMed ID: 2554525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The effects of various anticoagulants on blood coagulation: with special reference to false positive lupus anticoagulants].
    Onda H; Watanabe H
    Rinsho Byori; 1989 Dec; 37(12):1385-91. PubMed ID: 2515325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components.
    Siddiqui F; Hoppensteadt D; Bontekoe E; Farooqui A; Jeske W; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620954913. PubMed ID: 33030036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of a depolymerized holothurian glycosaminoglycan in plasma after intravenous administration by postcolumn HPLC.
    Huang Y; Toyoda H; Koshiishi I; Toida T; Imanari T
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2182-6. PubMed ID: 8582021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A cross-over study of a new low molecular weight heparin (Logiparin) in hemodialysis.
    Koutsikos D; Fourtounas C; Kapetanaki A; Dalamanga A; Tzanatos H; Agroyannis B; Kopelias I; Bosiolis B; Rammos G; Bovoleti O; Sallum G; Darema M
    Int J Artif Organs; 1996 Aug; 19(8):467-71. PubMed ID: 8841845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of optimal dosage of heparin in hemodialysis patients by thromboelastograph].
    Yang ST; Wu H; Gao XY; Hu J; Xiao YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):625-9. PubMed ID: 23939176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Anticoagulant effect of a single bolus injection of parnaparin sodium (LHG) on a hemodialysis model in dogs].
    Sugiyama T; Katai T; Okitsu M; Ohtawa M; Kodama T; Kanamori N; Kinugasa E; Akizawa T; Koshikawa S
    Nihon Yakurigaku Zasshi; 1994 Nov; 104(5):401-12. PubMed ID: 7829025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new low molecular weight heparinoid Org 10172 as anticoagulant in hemodialysis.
    Von Bonsdorff M; Stiekema J; Harjanne A; Alapiessa U
    Int J Artif Organs; 1990 Feb; 13(2):103-8. PubMed ID: 2347652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of unfractionated and low-molecular-weight heparin on platelet aggregation and in vitro bleeding time in dogs].
    Nimmerfall K; Mischke R
    Dtsch Tierarztl Wochenschr; 1999 Oct; 106(10):439-44. PubMed ID: 10589154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The components and activities analysis of a novel anticoagulant candidate dHG-5.
    Sun H; Gao N; Ren L; Liu S; Lin L; Zheng W; Zhou L; Yin R; Zhao J
    Eur J Med Chem; 2020 Dec; 207():112796. PubMed ID: 32942073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapeutic indications of low molecular weight heparins].
    Samama MM; Michaut-Paterno F
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1733-43. PubMed ID: 1662941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
    Jackson CV; Crowe VG; Frank JD; Wilson HC; Coffman WJ; Utterback BG; Jakubowski JA; Smith GF
    J Pharmacol Exp Ther; 1992 May; 261(2):546-52. PubMed ID: 1578372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of low-dose heparin in hemodialysis.
    Murea M; Russell GB; Daeihagh P; Saran AM; Pandya K; Cabrera M; Burkart JM; Freedman BI
    Hemodial Int; 2018 Jan; 22(1):74-81. PubMed ID: 28418614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.